Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Johannesson

Showing results (91-100 of 154) with videos related to

Pageof 16
Sort By:
Archives of Internal Medicine|September 26, 1994
Is misoprostol cost-effective in the prevention of nonsteroidal anti-inflammatory drug-induced gastropathy in patients with chronic arthritis? A review of conflicting economic evaluationsG Stucki, M Johannesson, M H Liang
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 31, 1997
Incorporating future costs in medical cost-effectiveness analysis: implications for the cost-effectiveness of the treatment of hypertensionM Johannesson, D Meltzer, R M O'Conor
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 1, 1993
Are healthy-years equivalents an improvement over quality-adjusted life years?M Johannesson, J S Pliskin, M C Weinstein
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 1, 1994
A note on QALYs, time tradeoff, and discountingM Johannesson, J S Pliskin, M C Weinstein
Health Policy (Amsterdam, Netherlands)|June 8, 1991
The costs of treating hypertension--an analysis of different cut-off pointsM Johannesson, L Borgquist, B Jönsson, et al.
Lakartidningen|March 20, 1991
[Treatment of hypertension in Sweden: treatment of patients with hypertension costs more than a billion crowns per year]M Johannesson, L Borgqvist, B Jönsson, et al.
Journal of Health Economics|May 29, 1999
A note on validating Wagstaff and van Doorslaer's health measure in the analysis of inequalities in healthU G Gerdtham, M Johannesson, L Lundberg, et al.
Journal of Internal Medicine|July 1, 1996
The cost effectiveness of lipid lowering in Swedish primary health care. The CELL Study GroupM Johannesson, L Borgquist, B Jönsson, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 7, 1999
The relationship between health-state utilities and the SF-12 in a general populationL Lundberg, M Johannesson, D G Isacson, et al.
Patient Education and Counseling|September 10, 1998
Cystic fibrosis through a female perspective: psychosocial issues and information concerning puberty and motherhoodM Johannesson, M Carlson, A B Brucefors, et al.
Pageof 16

Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
Archives of Internal Medicine|September 26, 1994
Is misoprostol cost-effective in the prevention of nonsteroidal anti-inflammatory drug-induced gastropathy in patients with chronic arthritis? A review of conflicting economic evaluationsG Stucki, M Johannesson, M H Liang
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 31, 1997
Incorporating future costs in medical cost-effectiveness analysis: implications for the cost-effectiveness of the treatment of hypertensionM Johannesson, D Meltzer, R M O'Conor
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 1, 1993
Are healthy-years equivalents an improvement over quality-adjusted life years?M Johannesson, J S Pliskin, M C Weinstein
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 1, 1994
A note on QALYs, time tradeoff, and discountingM Johannesson, J S Pliskin, M C Weinstein
Health Policy (Amsterdam, Netherlands)|June 8, 1991
The costs of treating hypertension--an analysis of different cut-off pointsM Johannesson, L Borgquist, B Jönsson, et al.
Lakartidningen|March 20, 1991
[Treatment of hypertension in Sweden: treatment of patients with hypertension costs more than a billion crowns per year]M Johannesson, L Borgqvist, B Jönsson, et al.
Journal of Health Economics|May 29, 1999
A note on validating Wagstaff and van Doorslaer's health measure in the analysis of inequalities in healthU G Gerdtham, M Johannesson, L Lundberg, et al.
Journal of Internal Medicine|July 1, 1996
The cost effectiveness of lipid lowering in Swedish primary health care. The CELL Study GroupM Johannesson, L Borgquist, B Jönsson, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 7, 1999
The relationship between health-state utilities and the SF-12 in a general populationL Lundberg, M Johannesson, D G Isacson, et al.
Patient Education and Counseling|September 10, 1998
Cystic fibrosis through a female perspective: psychosocial issues and information concerning puberty and motherhoodM Johannesson, M Carlson, A B Brucefors, et al.
Pageof 16